Venus Concept Stock Today
| VERO Stock | USD 0.34 0 0.85% |
Performance0 of 100
| Odds Of DistressOver 82
|
Venus Concept is selling at 0.3429 as of the 28th of November 2024; that is 0.85 percent increase since the beginning of the trading day. The stock's open price was 0.34. Venus Concept has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Venus Concept are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 5th of November 2012 | Category Healthcare | Classification Health Care |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company has 7.26 M outstanding shares of which 1.45 M shares are at this time shorted by private and institutional investors with about 0.69 trading days to cover. More on Venus Concept
Moving against Venus Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Venus Stock Highlights
| President COO | Hemanth CFA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsVenus Concept can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Venus Concept's financial leverage. It provides some insight into what part of Venus Concept's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Venus Concept (VERO) is traded on NASDAQ Exchange in USA. It is located in 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8 and employs 304 people. Venus Concept is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.45 M. Venus Concept conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 7.26 M outstanding shares of which 1.45 M shares are at this time shorted by private and institutional investors with about 0.69 trading days to cover.
Venus Concept currently holds about 6.78 M in cash with (12.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Venus Concept Probability Of Bankruptcy
Ownership AllocationVenus Concept has 6.07 % of its outstanding shares held by insiders and 27.03 % owned by institutional holders.
Check Venus Ownership Details
Venus Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Pacifica Partners Inc | 2024-09-30 | 120 | |
| Royal Bank Of Canada | 2024-06-30 | 36.0 | |
| Bank Of America Corp | 2024-06-30 | 34.0 | |
| Jpmorgan Chase & Co | 2024-06-30 | 4.0 | |
| Pfg Investments, Llc | 2024-06-30 | 0.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Citadel Advisors Llc | 2024-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2024-09-30 | 0.0 | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | |
| Essex Woodlands Health Ventures | 2024-09-30 | 1.1 M | |
| Masters Capital Management Llc | 2024-09-30 | 621.7 K |
Venus Concept Historical Income Statement
Venus Stock Against Markets
Venus Concept Corporate Management
| Anat Kotler | Head Management | Profile | |
| Anna Georgiadis | Chief Officer | Profile | |
| Jason Raser | Head USA | Profile | |
| Rajiv Silva | CEO Director | Profile | |
| Kenji Shimizu | Interim Officer | Profile | |
| Ross Portaro | Executive Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Venus Concept. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Venus Stock, please use our How to Invest in Venus Concept guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Venus Concept. If investors know Venus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Venus Concept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.97) | Revenue Per Share 11.915 | Quarterly Revenue Growth (0.17) | Return On Assets (0.19) | Return On Equity (4.64) |
The market value of Venus Concept is measured differently than its book value, which is the value of Venus that is recorded on the company's balance sheet. Investors also form their own opinion of Venus Concept's value that differs from its market value or its book value, called intrinsic value, which is Venus Concept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Venus Concept's market value can be influenced by many factors that don't directly affect Venus Concept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Venus Concept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Concept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Concept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.